<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="10" family="Times" color="#000000"/>
	<fontspec id="1" size="10" family="Times" color="#0000ff"/>
<text top="72" left="90" width="294" height="13" font="0">ENCODE DCC ANTIBODY VALIDATION DOCUMENT </text>
<text top="86" left="90" width="3" height="13" font="0"> </text>
<text top="100" left="90" width="141" height="13" font="0">Date of Submission: 6/22/11 </text>
<text top="114" left="90" width="3" height="13" font="0"> </text>
<text top="128" left="90" width="126" height="13" font="0">Name: Zarmik Moqtaderi </text>
<text top="141" left="90" width="3" height="13" font="0"> </text>
<text top="155" left="90" width="35" height="13" font="0">Email: </text>
<text top="155" left="125" width="126" height="13" font="1">Zarmik@hms.harvard.edu</text>
<text top="155" left="252" width="3" height="13" font="0"> </text>
<text top="169" left="90" width="3" height="13" font="0"> </text>
<text top="183" left="90" width="57" height="13" font="0">Lab: Struhl </text>
<text top="197" left="90" width="3" height="13" font="0"> </text>
<text top="210" left="90" width="115" height="13" font="0">Antibody Name: BRF2 </text>
<text top="224" left="90" width="3" height="13" font="0"> </text>
<text top="238" left="90" width="69" height="13" font="0">Target: BRF2 </text>
<text top="252" left="90" width="3" height="13" font="0"> </text>
<text top="266" left="90" width="424" height="13" font="0">Company/Source: Donated by Dr. RJ White, The Beatson Institute for Cancer Research </text>
<text top="279" left="90" width="112" height="13" font="0">antibody number 4295 </text>
<text top="293" left="90" width="3" height="13" font="0"> </text>
<text top="307" left="90" width="321" height="13" font="0">Catalog number or laboratory database ID: antibody number 4295 </text>
<text top="321" left="90" width="3" height="13" font="0"> </text>
<text top="335" left="90" width="66" height="13" font="0">Lot Number: </text>
<text top="348" left="90" width="3" height="13" font="0"> </text>
<text top="362" left="90" width="413" height="13" font="0">Antibody Description: Antibody 4295 against Brf2 was raised by immunizing rabbits </text>
<text top="376" left="90" width="434" height="13" font="0">with keyhole limpet hemocyanin coupled to synthetic peptides VSRSQQRGLRRVRDLC </text>
<text top="390" left="90" width="430" height="13" font="0">and SDSEIEQYLRTPQEVR, corresponding to human Brf2 residues 66-80 and 385-400, </text>
<text top="404" left="90" width="61" height="13" font="0">respectively </text>
<text top="417" left="90" width="3" height="13" font="0"> </text>
<text top="431" left="90" width="428" height="13" font="0">Target Description: Brf2 is a component of an alternate form of the RNA Polymerase III </text>
<text top="445" left="90" width="135" height="13" font="0">transcription factor TFIIIB. </text>
<text top="459" left="90" width="3" height="13" font="0"> </text>
<text top="473" left="90" width="119" height="13" font="0">Target Species:  Human </text>
<text top="486" left="90" width="3" height="13" font="0"> </text>
<text top="500" left="90" width="107" height="13" font="0">Host Species:  Rabbit </text>
<text top="514" left="90" width="3" height="13" font="0"> </text>
<text top="528" left="90" width="176" height="13" font="0">Validation Method 1:  Western Blot </text>
<text top="542" left="90" width="3" height="13" font="0"> </text>
<text top="555" left="90" width="378" height="13" font="0">Validation Method 2:  Correlation with known Pol III factors at expected loci. </text>
<text top="569" left="90" width="3" height="13" font="0"> </text>
<text top="583" left="90" width="104" height="13" font="0">Purification Method: </text>
<text top="597" left="90" width="3" height="13" font="0"> </text>
<text top="611" left="90" width="173" height="13" font="0">Polyclonal/Monoclonal: Polyclonal </text>
<text top="624" left="90" width="3" height="13" font="0"> </text>
<text top="638" left="90" width="406" height="13" font="0">Reference: Moqtaderi, Z., Wang, J., Raha, D., White R.J., Snyder M., Weng Z., and </text>
<text top="652" left="90" width="50" height="13" font="0">Struhl, K. </text>
<text top="666" left="90" width="404" height="13" font="0">Genomic binding profiles of functionally distinct RNA polymerase III transcription </text>
<text top="680" left="90" width="421" height="13" font="0">complexes in human cells.  Nat. Struct. Mol. Biol. 2010 May;17(5):635-40. Epub 2010 </text>
<text top="693" left="90" width="37" height="13" font="0">Apr 25.</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="72" left="90" width="430" height="13" font="0">Validation 1:  Western blotting with this antibody shows a strong band at the appropriate </text>
<text top="86" left="90" width="201" height="13" font="0">size in the ENCODE cell line GM12878: </text>
<text top="100" left="90" width="3" height="13" font="0"> </text>
<text top="252" left="153" width="3" height="13" font="0"> </text>
<text top="263" left="90" width="3" height="13" font="0"> </text>
<text top="277" left="90" width="405" height="13" font="0">Validation 2:  Brf2 is a component of an alternative form of the Pol III transcription </text>
<text top="291" left="90" width="427" height="13" font="0">factor TFIIIB, which is involved in the transcription of a small minority group of Pol III-</text>
<text top="305" left="90" width="399" height="13" font="0">transcribed genes with upstream extragenic promoters.  Brf2 is associated with the </text>
<text top="318" left="90" width="394" height="13" font="0">expected loci.  Although Brf2-bound loci recruit high levels of the Pol III subunit </text>
<text top="332" left="90" width="426" height="13" font="0">Rpc155, these loci are not associated with the more common TFIIIB subunit Brf1.  This </text>
<text top="346" left="90" width="383" height="13" font="0">is exactly the expected result for a component of an alternative TFIIIB subunit. </text>
<text top="360" left="90" width="172" height="13" font="0">This is illustrated in Figure 3 from: </text>
<text top="374" left="90" width="401" height="13" font="0">Moqtaderi, Z., Wang, J., Raha, D., White R.J., Snyder M., Weng Z., and Struhl, K. </text>
<text top="388" left="90" width="404" height="13" font="0">Genomic binding profiles of functionally distinct RNA polymerase III transcription </text>
<text top="401" left="90" width="421" height="13" font="0">complexes in human cells.  Nat. Struct. Mol. Biol. 2010 May;17(5):635-40. Epub 2010 </text>
<text top="415" left="90" width="37" height="13" font="0">Apr 25.</text>
<text top="418" left="127" width="2" height="10" font="2"> </text>
<text top="697" left="358" width="3" height="13" font="0"> </text>
</page>
</pdf2xml>
